商业快报

Ex-DeepMind scientist launches AI drug discovery venture

Simon Kohl aims to capitalise on his experience with Nobel Prize-winning AlphaFold protein prediction system
Latent Labs founder Simon Kohl said generative AI had the potential to change how drugmakers operate by making biology ‘programmable’

A scientist who helped build DeepMind’s Nobel Prize-winning protein prediction programme has raised $50mn to launch a company to discover new drugs. 

Simon Kohl has founded Latent Labs to capitalise on his experience working on the AI-powered AlphaFold2 system, which solved an important problem for life sciences researchers by allowing the prediction of the 3D structure of proteins based on their chemical composition. 

您已阅读20%(555字),剩余80%(2282字)包含更多重要信